Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00001876 · ClinicalTrials.gov registry record
Lung Disease Associated With Rheumatoid Arthritis
A clinical trial, sponsored by National Human Genome Research Institute (NHGRI).
- Completed
- Registry status
- 132
- Enrollment target
NCT00001876 is a clinical trial that has completed, run by National Human Genome Research Institute (NHGRI). The registered enrollment target is 132 participants.
The verdict
NCT00001876 has completed, sponsored by National Human Genome Research Institute (NHGRI).
- COMPLETED
- Registry status
- 132 participants
- Enrollment target
Study Summary
Pulmonary fibrosis (PF) is a condition in which the lungs of a patient become scarred and fibrous. It has been known to occur in as many as 40% of patients diagnosed with rheumatoid arthritis (RA). The cause of the pulmonary fibrosis in patients with RA is unknown. Patients participating in this study will undergo a series of tests and examinations before and throughout the study. The tests include blood and urine tests, electrical measures of heart function (ECG), chest x-rays, CAT scans, nuclear medicine scans, breathing tests, exercise tests, and fiberoptic bronchoscopy. The goals of this study are to: 1. Estimate how common pulmonary fibrosis is in patients with rheumatoid arthritis, 2. Describe the natural course of pulmonary fibrosis in patients with rheumatoid arthritis, 3. Estimate the survival rate of patients with pulmonary fibrosis and rheumatoid arthritis, and 4. Learn more about the factors that contribute to the development or progression fibrotic lung disease....
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 132 participants |
| Start Date | 1999-04-05 |
| Est. Completion | 2007-12-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00001876
The ClinicalTrials.gov registry entry for NCT00001876 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 132 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Human Genome Research Institute (NHGRI), which has 185 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00001876 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00001876 about?
NCT00001876 is a clinical study titled "Lung Disease Associated With Rheumatoid Arthritis". Pulmonary fibrosis (PF) is a condition in which the lungs of a patient become scarred and fibrous. It has been known to occur in as many as 40% of patients diagnosed with rheumatoid arthritis (RA). The cause of the pulmonary fibrosis in patients with RA is unknown. Patients participating in this st...
What is the current status of trial NCT00001876?
This trial is currently completed. The enrollment target is 132 participants. The study started on 1999-04-05. Estimated completion is 2007-12-11.
Who is sponsoring clinical trial NCT00001876?
This trial is sponsored by National Human Genome Research Institute (NHGRI), which has 185 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.